Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Inovio Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
Source: insidermonkey.com
Malignancy Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Malignancy Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Malignancy Consortium Today - Breaking & Trending Today
Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript
INO earnings call for the period ending June 30, 2023.
Source: fool.com
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update
Preparing to initiate pivotal Phase 3 trial of INO-3107 in adult RRP patients in first quarter of 2024; INO-3107 received Orphan Drug Designation from European...
Source: prnewswire.com
May Highlights Huntsman Cancer Institute Research
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Source: miragenews.com
Bay Area Reporter :: Screening, early treatment cut anal cancer risk
Screening people with HIV for precancerous anal cell changes and treating them early cuts the risk of anal cancer by more than half, according to results from the ANCHOR study published June 16 in the New England Journal of Medicine.
Source: ebar.com